PCN69 AN ECONOMIC EVALUATION OF DASATINIB FOR THE TREATMENT OF IMATINIB RESISTANT PATIENTS WITH ADVANCED PHASE CHRONIC MYELOGENOUS LEUKAEMIA

May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.924
https://www.valueinhealthjournal.com/article/S1098-3015(11)01063-1/fulltext
Section Title : Disease-Specific Studies
Section Order : 398
First Page : A167
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01063-1&doi=10.1016/j.jval.2011.02.924
HEOR Topics :
Tags :
Regions :